NEW YORK (GenomeWeb News) — The Government Accountability Office, the federal watchdog for government spending, said genomic technologies have reduced drug-development productivity while adding to R&D costs in recent years.
 
In a report it issued last month, “New Drug Development: Science, Business and Intellectual Property Issues Cited as Hampering Drug Development Efforts,” the GAO criticizes the slow pace and high costs of drug development and in one section blames genomic technologies.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.